Welcome to our dedicated page for Barclays Plc SEC filings (Ticker: BCLYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Barclays PLC (BCLYF) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures, with AI-powered tools to help interpret complex banking documents. Barclays files as a foreign issuer on Form 20-F and uses Form 6-K to furnish information originally released to The London Stock Exchange, covering topics that range from capital strength to share capital changes.
For users tracking Barclays’ capital position, the filings include a detailed statement on the Bank of England’s 2025 bank capital stress test. This disclosure presents common equity Tier 1, Tier 1 capital, total capital and leverage ratios, along with explanations of how these measures are defined under the UK Capital Requirements Regulation and the PRA Rulebook. AI-generated summaries can highlight the key ratios and what they imply for the bank’s resilience under stress scenarios.
Investors interested in equity structure and dilution can review multiple 6-K reports on transactions in Barclays’ own ordinary shares. These filings describe share buy-back programmes, daily purchases on the London Stock Exchange, the intention to cancel repurchased shares and the resulting issued share capital and total voting rights. Stock Titan’s interface, combined with AI, can make it easier to follow how these programmes affect outstanding shares over time.
This page also surfaces notifications of transactions by persons discharging managerial responsibilities and persons closely associated with them, which detail insider dealings in ordinary shares and American Depositary Shares. In addition, a Form 25 filing by the New York Stock Exchange LLC documents the removal from listing and/or registration of Barclays’ 4.375% Fixed Rate Senior Notes due 2026. Real-time updates from EDGAR, together with AI explanations, help users navigate these filings without reading every technical paragraph.
Barclays plc amended its Form 13F-HR to correct previously reported market values for holdings in the Q2-2024 report from thousands to exact dollar amounts. The amendment states there were no changes to positions; the Form 13F Information Table shows 9,424 entries with a total value of $327,101,700,678. The amendment was signed by Suejean Mott on 03-23-2026 and is strictly related to reporting accuracy.
Barclays PLC filed an amended Form 13F restating previously reported market values to exact dollar amounts; the amendment does not change any positions.
The amendment corrects values that were reported in thousands, lists 9,207 holdings entries, shows a Form 13F table value total of $376,799,329,696, and identifies 7 other included managers.
Barclays PLC amends its Form 13F holdings report to restate market values. This amendment corrects values previously reported in thousands to exact dollar amounts and does not change positions. The Form 13F Information Table shows 9,284 entries with a total market value of $356,858,095,963.
Barclays PLC reports share dealings involving Global Co-Head of Investment Banking Taylor Wright and a closely associated person. Computershare Investor Services plc, as administrator of Barclays' nominee service, disposed of 403,371 ordinary shares at £3.950 per share on the London Stock Exchange on 17 March 2026. In a separate transaction the same day, 516,512 shares were transferred from Computershare’s holding on behalf of Taylor Wright into a joint brokerage account in the names of Taylor Wright and L Wright outside a trading venue.
Barclays PLC filed an amended Form 13F-HR restating its Q1-2025 holdings report to correct market-value formatting: values originally reported in thousands were updated to exact dollar amounts. The amendment does not change positions; the report shows 10,620 holdings entries with a total market value of $352,710,489,171.
Barclays PLC reports a wide set of routine share-based remuneration transactions for senior managers. On 9 March 2026 it granted 7,801,804 Share Value Plan awards and 3,454,232 Long Term Incentive Plan awards, totalling 11,256,036 Shares with a gross value of £43,975,115, based on a Share price of £3.9068.
The trustee of the group benefit trusts also delivered Shares for fixed pay, prior-year awards and 2025 variable pay, and sold portions of these Shares to cover income tax and social security liabilities. American Depositary Shares were delivered under the Global Share Purchase Plan.
Barclays PLC has filed a Form 6-K reporting share transactions by senior managers. The notice covers disposals of ordinary shares of 25 pence each, carried out by Computershare Investor Services plc as administrator of Barclays' nominee service.
Group Chief Compliance Officer Matthew Fitzwater had 137,780 shares sold at £3.908 per share. Matthew Hammerstein, Chief Executive of the UK Corporate Bank, had 400,000 shares sold at £3.936 per share. Denny Nealon, CEO for Barclays US Consumer Bank and Barclays Bank Delaware, had 73,866 shares sold at £3.918 per share. All transactions took place on 9 March 2026 on the London Stock Exchange.
Barclays PLC has announced a leadership change at its European banking arm. Diony Lebot, an independent Non-Executive Director of Barclays PLC and Barclays Bank Ireland PLC (Barclays Europe), will become Chair of Barclays Europe and Chair of its Nominations Committee from 16 March 2026, following regulatory approval.
This appointment is in addition to her existing Barclays roles. She will succeed Tim Breedon, who will step down as a Non-Executive Director and as Chair of Barclays Europe and Chair of its Nominations Committee on the same date. The Boards thanked Mr Breedon for his stewardship and contribution during his tenure.
Barclays PLC reports extensive share capital activity, centred on its share buy-back programmes and routine insider dealings. The company completed the buy-back announced on 23 October 2025, having repurchased for cancellation 107,319,865 ordinary shares at a volume weighted average price of 465.8970p per share for total consideration of approximately £500 million.
Separately, under the buy-back launched on 10 February 2026, Barclays has purchased 41,431,750 ordinary shares on the London Stock Exchange at a volume weighted average price of 470.5603p per share as of 26 February 2026, all for cancellation. After recent cancellations, its issued share capital consists of 13,797,261,131 ordinary shares with voting rights, with no treasury shares, and 7,127,204 further shares were admitted to trading during January 2026.
The filing also details disposals and acquisitions of shares by senior executives and non-executive directors, including sales administered by Computershare, fee-based share acquisitions for board members at prices around £4.808 per share, and an option exercise resulting in the acquisition of 21,428 shares at £0.84 per share.